Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-034657
Filing Date
2011-06-03
Accepted
2011-06-03 14:49:12
Documents
2
Period of Report
2011-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd314219.html 3  
1 FORM 3 rrd314219.xml 3 2869
2 POWER OF ATTORNEY rrd281834_318198.htm EX-24. 4590
  Complete submission text file 0001181431-11-034657.txt   8882
Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459
Business Address 189 WELLS ST STE 200 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5118 HOLLY TERRACE HOUSTON TX 77056
Business Address
PRESSLER HERMAN PAUL (Reporting) CIK: 0001522481 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31791 | Film No.: 11891781